Influence of ambulatory inhaled treatment with different devices on the duration of acute asthma findings in children

Simple item page
dc.contributor.authorYilmaz O.
dc.contributor.authorSogut A.
dc.contributor.authorKose U.
dc.contributor.authorSakinci O.
dc.contributor.authorYuksel H.
dc.date.accessioned2024-07-22T08:21:56Z
dc.date.available2024-07-22T08:21:56Z
dc.date.issued2009
dc.description.abstractBackground. Efficacy of bronchodilator treatment in children with asthma depends on the proper use of inhalation devices. The aim of this study was to compare the efficacy of inhaled bronchodilator treatment with a spacer and a nebulizer in children with acute asthma findings. Methods. Fifty-eight children with acute asthma findings who received ambulatory inhaled bronchodilator treatment with a nebulizer and 39 with a spacer were enrolled in the study. Duration of asthma, inhaled steroid treatment and the number of exacerbations during the previous year were recorded. Duration of current acute symptoms, exacerbation severity score and duration of respiratory findings after initiation of treatment were also recorded. Results. Children in both groups were similar in age (76.5 > 30.3 months using a nebulizer vs 83.1 > 25.1 in spacer group, p = 0.26). Duration after diagnosis of asthma, initiation of inhaled steroid treatment and exacerbation symptoms were similar between groups (p = 0.15, 0.76 and 0.93, respectively). Exacerbation severity score in the nebulizer group was not significantly different from the spacer group (2.6 > 0.7 vs 2.8 > 0.7 respectively, p = 0.19). Number of exacerbations in the previous year was not different (2.0 > 1.2 in the nebulizer group vs 1.6 > 0.9 in the spacer group, p = 0.08). Duration of acute asthma findings after initiation of inhaled bronchodilator treatment was similar between the two groups (6.5 > 2.9 vs 7.2 > 4.6 p = 0.34). Conclusion. Nebulizers and spacers have similar influence on the duration of acute asthma findings in children when used in ambulatory home bronchodilator treatment.
dc.identifier.DOI-ID10.1080/02770900802604137
dc.identifier.issn15324303
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/18853
dc.language.isoEnglish
dc.subjectAdolescent
dc.subjectAlbuterol
dc.subjectAsthma
dc.subjectBronchodilator Agents
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectHumans
dc.subjectMetered Dose Inhalers
dc.subjectNebulizers and Vaporizers
dc.subjectSeverity of Illness Index
dc.subjectTime Factors
dc.subjectTreatment Outcome
dc.subjectbronchodilating agent
dc.subjectsalbutamol
dc.subjectsteroid
dc.subjectbronchodilating agent
dc.subjectsalbutamol
dc.subjectacute respiratory tract disease
dc.subjectadolescent
dc.subjectarticle
dc.subjectasthma
dc.subjectchild
dc.subjectcontrolled study
dc.subjectdisease duration
dc.subjectdisease exacerbation
dc.subjectdisease severity
dc.subjectdrug efficacy
dc.subjecthome respiratory care
dc.subjecthuman
dc.subjectinhalation spacer
dc.subjectmajor clinical study
dc.subjectmetered dose inhaler
dc.subjectnebulizer
dc.subjectoutpatient care
dc.subjectpreschool child
dc.subjectschool child
dc.subjectscoring system
dc.subjectsteroid therapy
dc.subjectasthma
dc.subjectclinical trial
dc.subjecthospitalization
dc.subjectmetered dose inhaler
dc.subjectnebulizer
dc.subjecttime
dc.subjecttreatment outcome
dc.titleInfluence of ambulatory inhaled treatment with different devices on the duration of acute asthma findings in children
dc.typeArticle

Files

Collections

Scopus Koleksiyonu